Clinical Trial Update: A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have Failed [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ALMB-0168 in adults with advanced solid tumors that have bone-only metastases; the trial status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors with Bone Metastases

Drugs mentioned

• ALMB-0168

Snippet

Sponsor: AlaMab Therapeutics (Shanghai) Inc. | Conditions: Advanced Solid Tumors With Bone Only Metastasis | Phase 2 | Status: NOT_YET_RECRUITING